MAPK Signaling

Activated MAPKs transduce the phosphorylation and activation of MAPK-activated protein kinases (MAPKAPKs), e.g. RSK, MSK, or MNK family, and MK2/3/5. There are three main MAPK families, signal-regulated kinase 1 and 2 (Erk1/2 or p44/42), the c-Jun N-terminal kinases 1-3 (JNK1-3)/ stress activated protein kinases (SAPK1A, 1B, 1C), the p38 isoforms (p38α, β, γ, and δ). ERK signaling is involved in cell division, migration and survival. p38 MAPK and JNK/SAPK pathways are activated by cellular stress. The p38 MAPK pathway regulates cell motility, transcription, and chromatin remodeling. JNK/SAPK signaling affects apoptosis and inflammation. Dysregulation of MAPK pathway results in tumorgenesis and other pathological conditions.
-   B3275 TCS JNK 5aTarget: JNKSummary: JNK2 and JNK3 inhibitor B3275 TCS JNK 5aTarget: JNKSummary: JNK2 and JNK3 inhibitor
-   C4338 AG-126Summary: ERK1 (p44) and ERK2 (p42) inhibitor C4338 AG-126Summary: ERK1 (p44) and ERK2 (p42) inhibitor
-   C5489 8-CPT-Cyclic AMP (sodium salt)Summary: lipophilic activator of the cyclic-AMP- and cyclic-GMP-dependent protein kinases, PKA and PKG C5489 8-CPT-Cyclic AMP (sodium salt)Summary: lipophilic activator of the cyclic-AMP- and cyclic-GMP-dependent protein kinases, PKA and PKG
-   A3018 Trametinib (GSK1120212)7 CitationTarget: MEKSummary: MEK1 and MEK2 inhibitor A3018 Trametinib (GSK1120212)7 CitationTarget: MEKSummary: MEK1 and MEK2 inhibitor
-   A3627 MLN 2480Summary: Pan-Raf kinase inhibitor,investigational A3627 MLN 2480Summary: Pan-Raf kinase inhibitor,investigational
-   A8687 VX-702Summary: P38α MAPK inhibitor,highly selective and ATP-competitive A8687 VX-702Summary: P38α MAPK inhibitor,highly selective and ATP-competitive
-   B1260 CC-401Summary: JNK inhibitor,ATP-competitive B1260 CC-401Summary: JNK inhibitor,ATP-competitive
-   C3921 Ulixertinib (hydrochloride)Summary: reversible ERK1/2 inhibitor C3921 Ulixertinib (hydrochloride)Summary: reversible ERK1/2 inhibitor
-   C4683 H-8 (hydrochloride)Summary: potent inhibitor of PKA and PKG C4683 H-8 (hydrochloride)Summary: potent inhibitor of PKA and PKG
-   A3016 PLX-47201 CitationTarget: RafSummary: BRAF kinase inhibitor A3016 PLX-47201 CitationTarget: RafSummary: BRAF kinase inhibitor
